May 1, 2017 — Corindus Vascular Robotics Inc. announced that Fu Wai Hospital in China performed and broadcast live a percutaneous coronary intervention (PCI) procedure using the CorPath GRX System to more than 4,000 attendees at the 22nd annual TCT Asia-Pacific Cardiovascular Summit.
The annual conference, being held April 25-27 in Seoul, South Korea, attracts attendees from 44 countries, with a majority of attendees from the Asia-Pacific region.
The CorPath GRX System, temporarily placed at Fu Wai Hospital for investigational use, is the first installation of the next-generation CorPath System outside of the United States. Kefei Dou, M.D., deputy director of coronary artery disease for the Department of Cardiology at Fu Wai Hospital, successfully performed the first robotic-assisted PCI procedures in Asia in March, with this case being the second one transmitted via live feed.
Fu Wai Hospital is the largest hospital in China and specializes in the treatment, prevention and research of cardiovascular diseases and hypertension and their related complications. According to Millennium Research Group, China is the second largest PCI market in the world.
CorPath GRX offers enhancements to the CorPath platform by adding key upgrades that increase precision, improve workflow, and extend the capabilities and range of procedures that can be performed robotically. Physicians now have independent and simultaneous robotic control of guide catheters, guidewires and balloon/stent catheters, with one-millimeter advancement capability, from the workstation console. This precise positioning that allows physicians to adjust guide catheters during PCI procedures may expand the use of the CorPath GRX System to more complex cases.
For more information: www.corindus.com
January 27, 2026 
